Creative Life Science (7837) Stock Overview
Manufactures and sells microbiology products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
7837 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more

Creative Life Science Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$115.50 |
| 52 Week High | NT$128.00 |
| 52 Week Low | NT$89.00 |
| Beta | 0 |
| 1 Month Change | 3.59% |
| 3 Month Change | 0.43% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 5.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7837 | TW Life Sciences | TW Market | |
|---|---|---|---|
| 7D | 3.6% | -1.2% | 3.7% |
| 1Y | n/a | -16.2% | 42.3% |
Return vs Industry: Insufficient data to determine how 7837 performed against the TW Life Sciences industry.
Return vs Market: Insufficient data to determine how 7837 performed against the TW Market.
Price Volatility
| 7837 volatility | |
|---|---|
| 7837 Average Weekly Movement | 4.2% |
| Life Sciences Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in TW Market | 9.1% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 7837 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 7837's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | n/a | n/a | www.cmp-micro.com |
Creative Life Science Co., Ltd. manufactures and sells microbiology products. The company’s primary product is Creative Media Plate (CMP), which offers prepared media, diagnostic reagents, and microbial related products for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. It offers transport medium, prepared tube media, prepared plated media, bacterial strain preservation systems, and CMP steripack triple wrapped media, as well as Viral Transport Medium (VTM) and Inactivation-VTM.
Creative Life Science Co., Ltd. Fundamentals Summary
| 7837 fundamental statistics | |
|---|---|
| Market cap | NT$2.58b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
Is 7837 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7837 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 7837 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/12 22:03 |
| End of Day Share Price | 2026/02/11 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Creative Life Science Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.